BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I, Di Leo A. Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol. 2007;25:2840-2846. [PMID: 17502626 DOI: 10.1200/jco.2006.09.7550] [Cited by in Crossref: 172] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Dazard JE, Sandlers Y, Doerner SK, Berger NA, Brunengraber H. Metabolomics of ApcMin/+ mice genetically susceptible to intestinal cancer. BMC Syst Biol 2014;8:72. [PMID: 24954394 DOI: 10.1186/1752-0509-8-72] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
2 Vignoli A, Ghini V, Meoni G, Licari C, Takis PG, Tenori L, Turano P, Luchinat C. High-Throughput Metabolomics by 1D NMR. Angew Chem Int Ed Engl. 2019;58:968-994. [PMID: 29999221 DOI: 10.1002/anie.201804736] [Cited by in Crossref: 101] [Cited by in F6Publishing: 69] [Article Influence: 33.7] [Reference Citation Analysis]
3 Weljie AM, Bondareva A, Zang P, Jirik FR. (1)H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system. J Biomol NMR 2011;49:185-93. [PMID: 21373841 DOI: 10.1007/s10858-011-9486-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
4 Wei S, Liu L, Zhang J, Bowers J, Gowda GA, Seeger H, Fehm T, Neubauer HJ, Vogel U, Clare SE, Raftery D. Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer. Mol Oncol 2013;7:297-307. [PMID: 23142658 DOI: 10.1016/j.molonc.2012.10.003] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 8.9] [Reference Citation Analysis]
5 Andres DA, Young LEA, Veeranki S, Hawkinson TR, Levitan BM, He D, Wang C, Satin J, Sun RC. Improved workflow for mass spectrometry-based metabolomics analysis of the heart. J Biol Chem 2020;295:2676-86. [PMID: 31980460 DOI: 10.1074/jbc.RA119.011081] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
6 Zhu X, Wang K, Liu G, Wang Y, Xu J, Liu L, Li M, Shi J, Aa J, Yu L. Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer. Gastroenterol Res Pract 2017;2017:5469597. [PMID: 28512469 DOI: 10.1155/2017/5469597] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Hart CD, Vignoli A, Tenori L, Uy GL, Van To T, Adebamowo C, Hossain SM, Biganzoli L, Risi E, Love RR, Luchinat C, Di Leo A. Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population. Clin Cancer Res 2017;23:1422-31. [PMID: 28082280 DOI: 10.1158/1078-0432.CCR-16-1153] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
8 Oakman C, Bessi S, Zafarana E, Galardi F, Biganzoli L, Di Leo A. Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer. Breast Cancer Res 2009;11:205. [PMID: 19435470 DOI: 10.1186/bcr2238] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
9 Guo YS, Tao JZ. 1H nuclear magnetic resonance-based plasma metabolomics provides another perspective of response mechanisms of newborn calves upon the first colostrum feeding. J Anim Sci 2018;96:1769-77. [PMID: 29733417 DOI: 10.1093/jas/sky078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Dittharot K, Jittorntam P, Wilairat P, Sobhonslidsuk A. Urinary Metabolomic Profiling in Chronic Hepatitis B Viral Infection Using Gas Chromatography/Mass Spectrometry. Asian Pac J Cancer Prev 2018;19:741-8. [PMID: 29582629 DOI: 10.22034/APJCP.2018.19.3.741] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Petereit DG, Burhansstipanov L. Establishing trusting partnerships for successful recruitment of American Indians to clinical trials. Cancer Control 2008;15:260-8. [PMID: 18596679 DOI: 10.1177/107327480801500310] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
12 Fleisher B, Clarke C, Ait-Oudhia S. Current advances in biomarkers for targeted therapy in triple-negative breast cancer. Breast Cancer (Dove Med Press) 2016;8:183-97. [PMID: 27785100 DOI: 10.2147/BCTT.S114659] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
13 Matos Do Canto L, Marian C, Varghese RS, Ahn J, Da Cunha PA, Willey S, Sidawy M, Rone JD, Cheema AK, Luta G, Nezami Ranjbar MR, Ressom HW, Haddad BR. Metabolomic profiling of breast tumors using ductal fluid. Int J Oncol 2016;49:2245-54. [PMID: 27748798 DOI: 10.3892/ijo.2016.3732] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
14 Cova TFGG, Bento DJ, Nunes SCC. Computational Approaches in Theranostics: Mining and Predicting Cancer Data. Pharmaceutics 2019;11:E119. [PMID: 30871264 DOI: 10.3390/pharmaceutics11030119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
15 Liu R, Peng Y, Li X, Wang Y, Pan E, Guo W, Pu Y, Yin L. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform. Int J Mol Sci. 2013;14:8899-8911. [PMID: 23615477 DOI: 10.3390/ijms14058899] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
16 Lodi A, Saha A, Lu X, Wang B, Sentandreu E, Collins M, Kolonin MG, DiGiovanni J, Tiziani S. Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism. NPJ Precis Oncol 2017;1:18. [PMID: 29202102 DOI: 10.1038/s41698-017-0024-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
17 Wang X, Xie G, Wang X, Zhou M, Yu H, Lin Y, Du G, Luo G, Liu P. Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients. Evid Based Complement Alternat Med 2015;2015:464969. [PMID: 25667596 DOI: 10.1155/2015/464969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
18 Podo F, Buydens LM, Degani H, Hilhorst R, Klipp E, Gribbestad IS, Van Huffel S, van Laarhoven HW, Luts J, Monleon D, Postma GJ, Schneiderhan-Marra N, Santoro F, Wouters H, Russnes HG, Sørlie T, Tagliabue E, Børresen-Dale AL; FEMME Consortium. Triple-negative breast cancer: present challenges and new perspectives. Mol Oncol 2010;4:209-29. [PMID: 20537966 DOI: 10.1016/j.molonc.2010.04.006] [Cited by in Crossref: 181] [Cited by in F6Publishing: 174] [Article Influence: 16.5] [Reference Citation Analysis]
19 Men Y, Li L, Zhang F, Kong X, Zhang W, Hao C, Wang G. Evaluation of heavy metals and metabolites in the urine of patients with breast cancer. Oncol Lett 2020;19:1331-7. [PMID: 31966065 DOI: 10.3892/ol.2019.11206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Lin JY, Juo BR, Yeh YH, Fu SH, Chen YT, Chen CL, Wu KP. Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics. BMC Bioinformatics 2021;22:305. [PMID: 34090341 DOI: 10.1186/s12859-021-04235-z] [Reference Citation Analysis]
21 Huang Z, Lin L, Gao Y, Chen Y, Yan X, Xing J, Hang W. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach. Mol Cell Proteomics. 2011;10:M111.007922. [PMID: 21799048 DOI: 10.1074/mcp.m111.007922] [Cited by in Crossref: 67] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
22 Denkert C, Bucher E, Hilvo M, Salek R, Orešič M, Griffin J, Brockmöller S, Klauschen F, Loibl S, Barupal DK, Budczies J, Iljin K, Nekljudova V, Fiehn O. Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery. Genome Med 2012;4:37. [PMID: 22546809 DOI: 10.1186/gm336] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
23 Ruhland E, Bund C, Outilaft H, Piotto M, Namer IJ. A metabolic database for biomedical studies of biopsy specimens by high-resolution magic angle spinning nuclear MR: a qualitative and quantitative tool. Magn Reson Med 2019;82:62-83. [PMID: 30847981 DOI: 10.1002/mrm.27696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Carotenuto D, Luchinat C, Marcon G, Rosato A, Turano P. The Da Vinci European BioBank: A Metabolomics-Driven Infrastructure. J Pers Med 2015;5:107-19. [PMID: 25913579 DOI: 10.3390/jpm5020107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Suravajhala P, Kogelman LJ, Kadarmideen HN. Multi-omic data integration and analysis using systems genomics approaches: methods and applications in animal production, health and welfare. Genet Sel Evol 2016;48:38. [PMID: 27130220 DOI: 10.1186/s12711-016-0217-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 63] [Article Influence: 17.6] [Reference Citation Analysis]
26 Wu J, Wu M, Wu Q. Identification of potential metabolite markers for colon cancer and rectal cancer using serum metabolomics. J Clin Lab Anal 2020;34:e23333. [PMID: 32281150 DOI: 10.1002/jcla.23333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR. 2011;49:231-243. [PMID: 21380509 DOI: 10.1007/s10858-011-9489-1] [Cited by in Crossref: 223] [Cited by in F6Publishing: 173] [Article Influence: 22.3] [Reference Citation Analysis]
28 Calabrò A, Gralka E, Luchinat C, Saccenti E, Tenori L. A metabolomic perspective on coeliac disease. Autoimmune Dis 2014;2014:756138. [PMID: 24665364 DOI: 10.1155/2014/756138] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
29 Wang L, Chen J, Chen L, Deng P, Bu Q, Xiang P, Li M, Lu W, Xu Y, Lin H. 1H-NMR based metabonomic profiling of human esophageal cancer tissue. Mol Cancer. 2013;12:25. [PMID: 23556477 DOI: 10.1186/1476-4598-12-25] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
30 Vlaanderen J, Moore LE, Smith MT, Lan Q, Zhang L, Skibola CF, Rothman N, Vermeulen R. Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup Environ Med. 2010;67:136-143. [PMID: 19933307 DOI: 10.1136/oem.2008.042788] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
31 Di Donato S, Vignoli A, Biagioni C, Malorni L, Mori E, Tenori L, Calamai V, Parnofiello A, Di Pierro G, Migliaccio I, Cantafio S, Baraghini M, Mottino G, Becheri D, Del Monte F, Miceli E, McCartney A, Di Leo A, Luchinat C, Biganzoli L. A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting. Cancers (Basel) 2021;13:2762. [PMID: 34199435 DOI: 10.3390/cancers13112762] [Reference Citation Analysis]
32 Cuadros-Inostroza A, Caldana C, Redestig H, Kusano M, Lisec J, Peña-Cortés H, Willmitzer L, Hannah MA. TargetSearch--a Bioconductor package for the efficient preprocessing of GC-MS metabolite profiling data. BMC Bioinformatics 2009;10:428. [PMID: 20015393 DOI: 10.1186/1471-2105-10-428] [Cited by in Crossref: 137] [Cited by in F6Publishing: 118] [Article Influence: 11.4] [Reference Citation Analysis]
33 Wang H, Wang L, Zhang H, Deng P, Chen J, Zhou B, Hu J, Zou J, Lu W, Xiang P, Wu T, Shao X, Li Y, Zhou Z, Zhao YL. ¹H NMR-based metabolic profiling of human rectal cancer tissue. Mol Cancer 2013;12:121. [PMID: 24138801 DOI: 10.1186/1476-4598-12-121] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
34 Deng L, Chang D, Foshaug RR, Eisner R, Tso VK, Wishart DS, Fedorak RN. Development and Validation of a High-Throughput Mass Spectrometry Based Urine Metabolomic Test for the Detection of Colonic Adenomatous Polyps. Metabolites. 2017;7:pii: E32. [PMID: 28640228 DOI: 10.3390/metabo7030032] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
35 Yu KH, Snyder M. Omics Profiling in Precision Oncology. Mol Cell Proteomics 2016;15:2525-36. [PMID: 27099341 DOI: 10.1074/mcp.O116.059253] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 10.6] [Reference Citation Analysis]
36 Chen Y, Ma Z, Min L, Li H, Wang B, Zhong J, Dai L. Biomarker identification and pathway analysis by serum metabolomics of lung cancer. Biomed Res Int 2015;2015:183624. [PMID: 25961003 DOI: 10.1155/2015/183624] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
37 McCartney A, Vignoli A, Tenori L, Fornier M, Rossi L, Risi E, Luchinat C, Biganzoli L, Di Leo A. Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification. NPJ Breast Cancer 2019;5:26. [PMID: 31482106 DOI: 10.1038/s41523-019-0123-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
38 Putluri N, Maity S, Kommagani R, Creighton CJ, Putluri V, Chen F, Nanda S, Bhowmik SK, Terunuma A, Dorsey T, Nardone A, Fu X, Shaw C, Sarkar TR, Schiff R, Lydon JP, O'Malley BW, Ambs S, Das GM, Michailidis G, Sreekumar A. Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance. Neoplasia 2014;16:390-402. [PMID: 25016594 DOI: 10.1016/j.neo.2014.05.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
39 Vahabi F, Sadeghi S, Arjmand M, Mirkhani F, Hosseini E, Mehrabanfar M, Hajhosseini R, Iravani A, Bayat P, Zamani Z. Staging of colorectal cancer using serum metabolomics with 1HNMR Spectroscopy. Iran J Basic Med Sci 2017;20:835-40. [PMID: 28852450 DOI: 10.22038/IJBMS.2017.9022] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
40 Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, Hanna N, Alexander HR, Hussain SP. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin Cancer Res. 2013;19:4983-4993. [PMID: 23918603 DOI: 10.1158/1078-0432.ccr-13-0209] [Cited by in Crossref: 150] [Cited by in F6Publishing: 95] [Article Influence: 18.8] [Reference Citation Analysis]
41 Hanash SM, Baik CS, Kallioniemi O. Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol. 2011;8:142-150. [PMID: 21364687 DOI: 10.1038/nrclinonc.2010.220] [Cited by in Crossref: 209] [Cited by in F6Publishing: 185] [Article Influence: 20.9] [Reference Citation Analysis]
42 Zekri AR, Youssef AS, Bakr YM, Gabr RM, Ahmed OS, Elberry MH, Mayla AM, Abouelhoda M, Bahnassy AA. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model. World J Gastroenterol 2016;22:4168-82. [PMID: 27122667 DOI: 10.3748/wjg.v22.i16.4168] [Reference Citation Analysis]
43 Taguchi A, Hanash SM. Unleashing the power of proteomics to develop blood-based cancer markers. Clin Chem. 2013;59:119-126. [PMID: 23099557 DOI: 10.1373/clinchem.2012.184572] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
44 Yang L, Yu QT, Ge YZ, Zhang WS, Fan Y, Ma CW, Liu Q, Qi LW. Distinct urine metabolome after Asian ginseng and American ginseng intervention based on GC-MS metabolomics approach. Sci Rep 2016;6:39045. [PMID: 27991533 DOI: 10.1038/srep39045] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
45 Wang H, Tso V, Wong C, Sadowski D, Fedorak RN. Development and validation of a highly sensitive urine-based test to identify patients with colonic adenomatous polyps. Clin Transl Gastroenterol 2014;5:e54. [PMID: 24646506 DOI: 10.1038/ctg.2014.2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
46 Sun L, Kang Q, Pan Y, Li N, Wang X, He Y, Wang H, Yu D, Xie H, Yang L, Lu Y, Jin P, Sheng J. Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry. Cancer Biol Ther 2019;20:1017-28. [PMID: 30983515 DOI: 10.1080/15384047.2019.1595277] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
47 Cha MH, Jones AD, Ko MM, Zhang C, Lee MS. Metabolic Profiles Distinguish Non-Dampness-Phlegm and Dampness-Phlegm Patterns among Korean Patients with Acute Cerebral Infarction. Evid Based Complement Alternat Med 2013;2013:517018. [PMID: 23573132 DOI: 10.1155/2013/517018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Rundle A, Ahsan H, Vineis P. Better cancer biomarker discovery through better study design. Eur J Clin Invest 2012;42:1350-9. [PMID: 22998109 DOI: 10.1111/j.1365-2362.2012.02727.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
49 Zhu K, Dai Z, Zhou J. Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy. Biomark Res. 2013;1:10. [PMID: 24252133 DOI: 10.1186/2050-7771-1-10] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
50 Cazzaniga P, Damiani C, Besozzi D, Colombo R, Nobile MS, Gaglio D, Pescini D, Molinari S, Mauri G, Alberghina L, Vanoni M. Computational strategies for a system-level understanding of metabolism. Metabolites 2014;4:1034-87. [PMID: 25427076 DOI: 10.3390/metabo4041034] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 5.4] [Reference Citation Analysis]
51 Chen F, Xue J, Zhou L, Wu S, Chen Z. Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method. Anal Bioanal Chem 2011;401:1899-904. [PMID: 21833635 DOI: 10.1007/s00216-011-5245-3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
52 Assfalg M, Bertini I, Colangiuli D, Luchinat C, Schäfer H, Schütz B, Spraul M. Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci USA. 2008;105:1420-1424. [PMID: 18230739 DOI: 10.1073/pnas.0705685105] [Cited by in Crossref: 189] [Cited by in F6Publishing: 161] [Article Influence: 14.5] [Reference Citation Analysis]
53 Wilkinson DJ. Historical and contemporary stable isotope tracer approaches to studying mammalian protein metabolism. Mass Spectrom Rev 2018;37:57-80. [PMID: 27182900 DOI: 10.1002/mas.21507] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 7.2] [Reference Citation Analysis]